Grantham, Mayo, Van Otterloo & Co (GMO)’s Willis Towers Watson WTW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-74,180
Closed -$14.9M – 785
2022
Q3
$14.9M Sell
74,180
-17,769
-19% -$3.67M 0.09% 205
2022
Q2
$18.1M Sell
91,949
-159,136
-63% -$34.1M 0.1% 200
2022
Q1
$59.3M Sell
251,085
-244,655
-49% -$56M 0.29% 61
2021
Q4
$118M Sell
495,740
-284,634
-36% -$67.4M 0.57% 36
2021
Q3
$181M Buy
780,374
+125,096
+19% +$27.8M 0.9% 29
2021
Q2
$151M Buy
655,278
+46,255
+8% +$11.5M 0.75% 32
2021
Q1
$139M Sell
609,023
-945
-0.2% -$206K 0.76% 33
2020
Q4
$129M Buy
609,968
+147,768
+32% +$30.4M 0.79% 35
2020
Q3
$96.5M Buy
462,200
+42,000
+10% +$8.58M 0.69% 38
2020
Q2
$82.8M Buy
420,200
+94,740
+29% +$18.1M 0.61% 40
2020
Q1
$55.3M Buy
+325,460
New +$64M 0.46% 49

Other funds holding WTW

Grantham, Mayo, Van Otterloo & Co (GMO)'s WTW Position: Q4 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Willis Towers Watson (WTW) in Q4 2022, closing a stake of 74,180 shares — an estimated $14.9M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in WTW in Q1 2020 and held it in 11 quarters. The position peaked at $181M in Q3 2021. 597 funds tracked by Wall St. Rank hold WTW as of Q4 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Willis Towers Watson position as of Q4 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 74,180 Willis Towers Watson shares in Q4 2022, an estimated $14.9M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Willis Towers Watson in Q1 2020 and held it in 11 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Willis Towers Watson position peaked at $181M in Q3 2021.
  • 597 funds tracked by Wall St. Rank held Willis Towers Watson as of Q4 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2022, filed 13 Feb 2023.